A Prospective Trial of Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide for Newly Diagnosed Glioblastoma Multiforme
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 08 Dec 2015
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 19 Nov 2015 Planned end date changed from 1 May 2015 to 1 Jan 2016, as reported by ClinicalTrials.gov.
- 19 Nov 2015 Planned primary completion date changed from 1 May 2015 to 1 Jan 2016, as reported by ClinicalTrials.gov.
- 26 Nov 2011 New trial record